<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457506</url>
  </required_header>
  <id_info>
    <org_study_id>NL52329.075.15</org_study_id>
    <nct_id>NCT03457506</nct_id>
  </id_info>
  <brief_title>Intra-individual Comparison of Conventional and Digital PET/CT Scanners</brief_title>
  <official_title>Intra-individual Patient-based Comparison of Conventional and Digital PET/CT Scanners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isala</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philips Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Isala</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will analyze the impact of digital PET/CT on the final
      diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal
      cancer and a group of mescellaneous cancers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There will be a single injection of the PET radiopharmaceutical FDG, followed by a
      conventional PET/CT scan and a digital PET scan, in this order or vice versa.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">January 2, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All included patients will have two PET scans, one on the conventional PET (Ingenuity TF, Philips Healthcare) and one on the digital PET (Vereos, Philips Healthcare). The order of the two PET scans will differ per patient.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic outcome of the PET/CT study</measure>
    <time_frame>approximately 2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PET image quality</measure>
    <time_frame>approximately 2 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Lung Cancer</condition>
  <condition>Esophageal Cancer</condition>
  <condition>Miscellaneous Neoplasm</condition>
  <arm_group>
    <arm_group_label>Patients undergo a digital PET/CT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm prospective study of paired PET scans. Patients who are referred to the nuclear medicine department to undergo a PET scan, will undergo a PET/CT scan on the conventional scanner as well as the digital PET/CT scanner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Digital PET/CT scan</intervention_name>
    <description>The digital PET/CT scan will be acquired before or after the conventional PET/CT scan.</description>
    <arm_group_label>Patients undergo a digital PET/CT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

        In order to be eligible to participate in this study, a subject must meet all of the
        following criteria:

          -  referred to Isala for a clinically indicated FDG-PET/CT scan

          -  suspected or proven lung cancer, esophageal cancer, breast cancer or miscellaneous
             cancer, either as a primary diagnosis or follow-up study

          -  signed informed consent

        Exclusion criteria

        A potential subject who meets any of the following criteria will be excluded from
        participation in this study:

          -  age &lt; 18 years

          -  incapacitated adults

          -  prisoners

          -  pregnant patients

          -  unable to undergo two consecutive PET/CT scans
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pieter L Jager, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>p.l.jager@isala.nl</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danielle Koopman, MSc</last_name>
    <phone>038 424 2107</phone>
    <email>d.koopman@isala.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pieter L Jager, MD PhD</last_name>
    <phone>038 424 2107</phone>
    <email>p.l.jager@isala.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Isala</name>
      <address>
        <city>Zwolle</city>
        <state>Overijssel</state>
        <zip>8025AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Koopman, MSc</last_name>
      <phone>038-4242107</phone>
      <email>d.koopman@isala.nl</email>
    </contact>
    <contact_backup>
      <last_name>Piet L Jager, MD PhD</last_name>
      <phone>038-4242107</phone>
      <email>p.l.jager@isala.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2017</study_first_submitted>
  <study_first_submitted_qc>February 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isala</investigator_affiliation>
    <investigator_full_name>Piet Jager</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Digital pet</keyword>
  <keyword>Conventional pet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

